Alnylam's Amvuttra enters ATTR-CM drug race, and Expedition Therapeutics seeks to bring Chinese drugs to the U.S.

How GLP-1 drugs, regulatory concerns, and more factors are shaping the sector. Plus, 3 undervalued healthcare stocks.

The Cigna Group Completes Sale of Medicare Businesses to HCSC The transaction is not expected to disrupt coverage or s ...

Both semaglutide and tirzepatide would need big price cuts to be seen as a good buy for the US healthcare system.

Spring has nearly sprung and round two of the Inflation Reduction Act (IRA)’s negotiation period has begun. | All of the ...

Novo Nordisk shares rose Monday as the company said it would present new data on the ability of semaglutide, the active ...

Wegovy is a prescription medication designed for chronic weight management, offering hope to individuals struggling with ...

All pharmaceutical manufacturers, including Novo Nordisk (NYSE:NVO) and Teva Pharmaceuticals, have agreed to participate in ...

All drug manufacturers, including Novo Nordisk and Teva Pharmaceuticals , whose medicines are part of the second round of ...

A new study found that fair prices for medications like Wegovy and Zepbound would be hundreds less per month than they are ...

Stocks: Real-time U.S. stock quotes reflect trades reported through Nasdaq only; comprehensive quotes and volume reflect trading in all markets and are delayed at least 15 minutes. International ...

Stocks: Real-time U.S. stock quotes reflect trades reported through Nasdaq only; comprehensive quotes and volume reflect trading in all markets and are delayed at least 15 minutes. International ...